Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

FDA raises legal issues re use of HCG for weight loss

By Michael H. Cohen on January 24, 2011
Email this postTweet this postLike this postShare this post on LinkedIn

Physician use of HCG for weight loss raises legal issues that the FDA has now flagged.

USA Today reported in a story titled, HCG weight-loss products are fraudulent, FDA says.

The article quoted an FDA official as hinting that FDA could step up enforcement actions concerning use of HCG for weight loss.  According to the article by reporter Nanci Hellmich:

HCG weight-loss products that promise dramatic results and claim to be homeopathic are sold as drops, pellets and sprays on the Web, in drugstores and at General Nutrition Centers. They are supposed to be used in combination with a very low-calorie diet of 500 calories a day.

Many of the labels indicate the products contain HCG, or human chorionic gonadotropin, a hormone made by the placenta during pregnancy. The hormone itself is approved as a prescription treatment for infertility and other conditions.

There is no evidence the oral over-the-counter products are effective for weight loss, says Elizabeth Miller, FDA’s leader for the Internet and health fraud team. While they may not be dangerous, they’re at least “economic fraud,” she says.

Because the products do not seem to be “a serious direct health hazard or a serious indirect health hazard,” they have been a lower priority for FDA action than other products. Still, Miller says, “they could be subject to enforcement at any time.”

One of the issues is the homeopathic label. Homeopathy is an alternative medicine practice of using very small or diluted preparations of medicines or remedies to treat a condition. Miller says, “We are aware of HCG products that claim to be homeopathic, but it is not recognized in the Homeopathic Pharmacopoeia.” Therefore, these products “are not recognized by the FDA as homeopathic drugs, so they are unapproved drugs and are illegal,” she says…..

FDA’s Miller also has concerns about injectable versions of HCG for weight loss. The drug is not approved for weight loss, she says. Dieters getting injections of the hormone from people who aren’t licensed to do so run the risk of getting infections and can’t be sure what product they’re getting.

The FDA has jurisdiction over interstate commerce and thus can go after manufacturers and distributors of HCG with a variety of enforcement tools.  In any legal analysis of FDA issues involving HCG, there are always two questions: one, what does the law say; and two, what are the enforcement priorities and how likely is it that the FDA will take action?

In addition, while the FDA regulates distribution of drugs in interstate commerce, state law governs the practice of medicine and other health care professions.  Physicians and pharmacies dispensing HCG as subject to state medical practice acts and state pharmacy laws.

Under federal law, HCG cannot be dispensed without a prescription and is a controlled substance under the federal Controlled Substances Act.  In addition, HCG would fall within the federal Ryan Haight Act which regulates Internet pharmacies, telemedicine involving prescriptions, and sales of pharmaceutical drugs off the Internet.

Photo of Michael H. Cohen Michael H. Cohen

Michael served as Assistant Professor of Medicine at Harvard Medical School and Adjunct faculty at Harvard School of Public Health.  He is Author of 6 leading books on Health and Wellness Law. Recognized for his contribution to international health law and policy. Michael…

Michael served as Assistant Professor of Medicine at Harvard Medical School and Adjunct faculty at Harvard School of Public Health.  He is Author of 6 leading books on Health and Wellness Law. Recognized for his contribution to international health law and policy. Michael is a thought leader in health care law, pioneering legal strategies and solutions for clients in traditional and emerging healthcare markets.

Read more about Michael H. CohenEmailMichael H.'s Twitter ProfileMichael H.'s Facebook Profile
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Cam Law
  • Organization:
    Michael H. Cohen

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo